BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260130T000000
DTEND;TZID=Europe/Vienna:20280130T235959
DTSTAMP:20260510T142745
CREATED:20260113T132906Z
LAST-MODIFIED:20260223T101002Z
UID:3455-1769731200-1832889599@esmit.eanm.org
SUMMARY:Personalized Medicine in Prostate Cancer: From Diagnostic to Therapy
DESCRIPTION:This course has been accredited with 3 CME credits by the UEMS EACCME. \n\n\n\nRadiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy is an efficacious new treatment option in patients with metastatic castration-resistant prostate cancer (mCRPC) and beyond. The online course will cover the spectrum of radiolabelled PSMA tracers\, techniques related to PSMA imaging\, from diagnosis to therapy\, with lectures\, interactive case discussions\, and relevant information for clinical practice. \n\n\n\n \n\n\n\n\n\n\n\nSave yourself a seat!Enter the eLearning platform  register for the course. Having trouble? See the short tutorial here. Register now!\n\n\n\n\n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n \n\n\n\nPSMA PET-CT imaging- science and practice:  \n\n\n\n\nTo provide an overview of clinical applications\, normal biodistribution\, variants\, pitfalls and artefacts in PSMA PET-CT \n\n\n\nTo learn how to report PSMA PET-CT scans in primary staging and recurrence\n\n\n\n\n \n\n\n\nRadionuclide PSMA therapy-science and practice (177Lu-PSMA therapies): \n\n\n\n\nTo gain knowledge on PSMA patients selection\, management of common clinical challenges in implementing and delivering of radionuclide therapies\, side effects and their management\n\n\n\nTo discuss current evidence and trends related to 177Lu-PSMA therapies \n\n\n\nTo learn about new or emerging targets and radioisotopes for Prostate cancer management\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\nGeneral nuclear medicine specialists\, residents\, radiologists\, healthcare specialists who want to update their knowledge on molecular imaging and radionuclide therapy of prostate cancer including theranostics. \n\n\n\n \n\n\n\n\n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nKarolien GoffinSpeaker \n\n\n\n\n\nWolfgang FendlerSpeaker
URL:https://esmit.eanm.org/event/personalized-medicine-in-prostate-cancer-from-diagnostic-to-therapy/
ORGANIZER;CN="ESMIT":MAILTO:esmit@eanm.org
END:VEVENT
END:VCALENDAR